SMTL ID : 4an3.1

Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (GDC-0973), or related analogs.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 5 residues within 4Å: Chain A: K.40, S.137, N.138, D.151 Ligands: ATP.2 3 PLIP interactions: 1 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:D.151, H2O.2, H2O.2

1 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)

ATP.2: 22 residues within 4Å: Chain A: L.17, A.19, G.20, N.21, G.23, V.25, A.38, K.40, V.70, M.86, E.87, H.88, M.89, S.93, Q.96, K.135, S.137, N.138, L.140, D.151 Ligands: MG.1, 5Y0.3 16 PLIP interactions: 16 interactions with chain A Hydrogen bonds: A:N.21, A:G.23, A:E.87, A:M.89, A:S.93, A:S.93, A:S.93, A:D.133, A:S.137, A:S.137 Water bridges: A:K.40, A:K.135, A:N.138 Salt bridges: A:K.40, A:K.135, A:K.135

1 x 5Y0: N-[(2S)-2,3-bis(oxidanyl)propoxy]-3,4-bis(fluoranyl)-2-[(2-fluoranyl-4-iodanyl-phenyl)amino]benzamide(Non-covalent)

5Y0.3: 16 residues within 4Å: Chain A: N.21, G.22, K.40, I.42, L.58, L.61, V.70, I.84, M.86, D.151, F.152, G.153, V.154, S.155, L.158 Ligands: ATP.2 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.61, A:I.84, A:L.158 Hydrogen bonds: A:G.22, A:K.40 Halogen bonds: A:V.70

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rice, K.D. et al., Novel Carboxamide-Based Allosteric Mek Inhibitors: Discovery and Optimization Efforts Toward Xl518 (Gdc-0973). Acs Med.Chem.Lett. (2012)

Release Date

2012-12-19

Peptides

DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1

Related Entries With Identical Sequence